ID   OCI-P2a
AC   CVCL_DH15
DR   cancercelllines; CVCL_DH15
DR   ECACC; 20012004
DR   GEO; GSM1001401
DR   GEO; GSM1001438
DR   GEO; GSM1001466
DR   Progenetix; CVCL_DH15
DR   Wikidata; Q54931792
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; Simple; p.Arg267Gly (c.799C>G); ClinVar=VCV001761541; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: Transcriptomics; Microarray.
CC   Omics: Variations; SNP array analysis.
CC   Derived from site: Metastatic; Ascites; UBERON=UBERON_0007795.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11
ST   D13S317: 11,12
ST   D16S539: 12,13
ST   D5S818: 12
ST   D7S820: 9,11
ST   TH01: 9,9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C7550; Ovarian serous adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 10-04-25; Version: 11
//
RX   PubMed=26080861; DOI=10.1038/ncomms8419; PMCID=PMC4473807;
RA   Ince T.A., Sousa A.D., Jones M.A., Harrell J.C., Agoston E.S.,
RA   Krohn M., Selfors L.M., Liu W.-B., Chen K., Yong M., Buchwald P.,
RA   Wang B., Hale K.S., Cohick E., Sergent P., Witt A., Kozhekbaeva Z.M.,
RA   Gao S.-Z., Agoston A.T., Merritt M.A., Foster R., Rueda B.R., Crum C.P.,
RA   Brugge J.S., Mills G.B.;
RT   "Characterization of twenty-five ovarian tumour cell lines that
RT   phenocopy primary tumours.";
RL   Nat. Commun. 6:7419.1-7419.14(2015).
//